Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Koiti, Inokuchi"'
Autor:
Yusuke Kajimoto, Yasuhiro Terasaki, Mika Terasaki, Shinobu Kunugi, Yugo Okabe, Satoshi Wakita, Koiti Inokuchi, Akira Shimizu
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Epstein–Barr virus (EBV) is associated with the pathogenesis of a variety of malignancies, most notably lymphomas. Especially in the background of immunodeficiency, such as primary immunodeficiency disorder (PID) and post-transp
Externí odkaz:
https://doaj.org/article/29717c32bb06495f8a903ee15eb692e8
Autor:
Masahiro, Sakaguchi, Yasunobu, Nagata, Yasuhiro, Terasaki, Atsushi, Takeyoshi, Syunichi, Yasuda, Shunsuke, Honma, Ryosuke, Kinoshita, Atsushi, Marumo, Toshio, Asayama, Shunsuke, Yui, Satoshi, Wakita, Muneo, Okamoto, Yusuke, Kajimoto, Koiti, Inokuchi, Hiroki, Yamaguchi
Publikováno v:
Journal of Nippon Medical School. 90:126-135
Hemophagocytic lymphohistiocytosis (HLH) involves pathological histiocytes and phagocytosis of normal blood cells through activation of inflammatory cytokines. We report a case of Epstein-Barr virus-HLH in a 75-year-old woman who presented with fever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5944e9e34705ca0bebb7690193d79f7
https://doi.org/10.1272/jnms.jnms.2023_90-105
https://doi.org/10.1272/jnms.jnms.2023_90-105
Autor:
Masahiro Sakaguchi, Nana Nakajima, Hiroki Yamaguchi, Yuho Najima, Katsuhiro Shono, Atsushi Marumo, Ikuko Omori, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Satoshi Wakita, Miho Mitaya, Kunihito Arai, Tomoaki Kitano, Noriko Doki, Kazuteru Ohashi, Koiti Inokuchi
Publikováno v:
Leukemia Research Reports, Vol 13, Iss , Pp 100198- (2020)
Fms-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) is a key predictive factor for the prognosis of acute myeloid leukemia (AML). We compared the detection sensitivity of fragment analysis with that of PCR-electrophoresis using MV4-11 (
Externí odkaz:
https://doaj.org/article/83de8e6f78e142848c9d98dcfaf08594
Publikováno v:
Leukemia Research Reports, Vol 7, Iss C, Pp 2-5 (2017)
Primary esophageal lymphoma is an extremely rare disease. We report a 76-year-old woman with esophageal lymphoma who achieved remission after Helicobacter pylori (HP) eradication. Esophagogastroduodenoscopy (EGD) revealed a mass in the lower esophagu
Externí odkaz:
https://doaj.org/article/5ea63c4a4479426b9d470b83ebde5b08
Autor:
Koiti Inokuchi, Koji Tamada, Inhak Choi, Keiichi Moriya, Yasuko Hamada, Namiko Okuyama, Asaka Kondo-Onodera, Mika Sunakawa, Hideto Tamura, Mariko Ishibashi
B7 homolog 1 (B7-H1)–expressing myeloma cells not only inhibit myeloma-specific cytotoxic T lymphocytes (CTL), but also confer a proliferative advantage: resistance to antimyeloma chemotherapy. However, it remains unknown whether B7-H1 expressed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b44c7f9302111a8db44f05ec01e8f1ee
https://doi.org/10.1158/2326-6066.c.6548588.v1
https://doi.org/10.1158/2326-6066.c.6548588.v1
Autor:
Hideto Tamura, Rimpei Morita, Koiti Inokuchi, Mika Sunakawa-Kii, Hiroshi Handa, Takumi Ito, Junichi Yamamoto, Mariko Ishibashi
We previously showed that the interaction of programmed death-ligand 1 (PD-L1) on multiple myeloma (MM) cells with PD-1 not only inhibits tumor-specific cytotoxic T-lymphocyte activity via the PD-1 signaling pathway but also induces drug resistance v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c24f7df0cc6a46b3d564efeb21b942b
https://doi.org/10.1158/1535-7163.c.6543444.v1
https://doi.org/10.1158/1535-7163.c.6543444.v1
Autor:
Hideto Tamura, Rimpei Morita, Koiti Inokuchi, Mika Sunakawa-Kii, Hiroshi Handa, Takumi Ito, Junichi Yamamoto, Mariko Ishibashi
Supplementary Materials and methods; Supplementary Table S1: Cell characteristics and phenotypes of MM cell lines; Supplementary Table S2: Characteristics of patients with newly diagnosed MM in Figure 1H; Supplementary Table S3: Primer and shRNA sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee3bf352fe8190d2ff114f9b41538dad
https://doi.org/10.1158/1535-7163.22522599.v1
https://doi.org/10.1158/1535-7163.22522599.v1
Autor:
Hideto Tamura, Koiti Inokuchi, Hiroki Sugimori, Takeshi Odajima, Junji Tanaka, Norio Komatsu, Keiichi Moriya, Asaka Onodera, Yasuko Kuribayashi-Hamada, Yuta Kaito, Mika Sunakawa, Toshio Asayama, Shigeki Ito, Sakae Tanosaki, Yutaka Tsukune, Norina Tanaka, Yoichi Imai, Hiroshi Handa, Makoto Sasaki, Asako Tsubota, Risa Takahashi, Mariko Ishibashi
Table S1. Primer sequences Table S2. Patient characteristics in cell - surface SLAMF3 and CD138 expression analysis. Table S3. One hundred and sixty-eight gene sets that were significantly upregulated in SLAMF3-KMS34 cells compared with Î"SLAMF3 cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1760c121042202d5de50c257c0692d93
https://doi.org/10.1158/1541-7786.22514517.v1
https://doi.org/10.1158/1541-7786.22514517.v1
Autor:
Koiti Inokuchi, Koji Tamada, Inhak Choi, Keiichi Moriya, Yasuko Hamada, Namiko Okuyama, Asaka Kondo-Onodera, Mika Sunakawa, Hideto Tamura, Mariko Ishibashi
Supplementary Table S1 Primer Sequence. Supplementary Figure S1. (A) Surface antigen expression and (B) Cell morphology of MOSTI-1 cells, and (C) drug sensitivity to melphalan and bortezomib of MOSTI-1, U266, and RPMI8226 cells. Supplementary Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91798621635efee147057d1e41e6c5d4
https://doi.org/10.1158/2326-6066.22537886.v1
https://doi.org/10.1158/2326-6066.22537886.v1
Autor:
Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, Ryosuke Kinoshita, Daishi Onai, Mika Sunakawa, Yuta Kaito, Kazuki Inai, Taichiro Tokura, Atsushi Takeyoshi, Shunichi Yasuda, Shunsuke Honma, Kazutaka Nakayama, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Muneo Okamoto, Koiti Inokuchi, Hiroki Yamaguchi
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 19:136-148
The MEAM regimen consisting of ranimustine (MCNU), etoposide (ETP), cytarabine (Ara-C), and melphalan (MEL) is widely used before auto-peripheral blood stem cell transplantation (auto-PBSCT) for malignant lymphoma in Japan. The MEAM regimen generally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8be6464db2b4a90ff82f4c7f4c9eefb
https://doi.org/10.1111/ajco.13780
https://doi.org/10.1111/ajco.13780